Fortress Biotech, Inc. Value of Shares Repurchased and Retired
Fortress Biotech, Inc. (FBIO) reported Value of Shares Repurchased and Retired of $17.60 thousand for the 1-month period ending 2016-10-31, per its 10-K filed 2017-03-16.
Discontinued › Shareholders' Equity
us-gaap:StockRepurchasedAndRetiredDuringPeriodValue · last filed 2017-03-16
- 2016-10-31: Stock Repurchased and Retired During Period, Value 1 month $17.60K.
| Period end | Stock Repurchased and Retired During Period, Value 1 month |
|---|---|
| 2016-10-31 | $17.60K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |